Yahoo Finance Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.
Life and the stock market are both about expectations, and rising above what is expected is often rewarded, while falling short can come with negative consequences. Investors might want to try to capture stronger returns by finding positive earnings surprises.
2 Stocks to Add to Your Watchlist
The Zacks Expected Surprise Prediction, or ESP, works by locking in on the most up-to-date analyst earnings revisions because they can be more accurate than estimates from weeks or even months before the actual release date. The thinking is pretty straightforward: analysts who provide earnings estimates closer to the report are likely to have more information. With this in mind, the Expected Surprise Prediction compares the Most Accurate Estimate (being the most recent) against the overall Zacks Consensus Estimate. The percentage difference provides the ESP figure.
Now that we understand what the ESP is and how beneficial it can be, let's dive into a stock that currently fits the bill. United Therapeutics (UTHR) earns a Zacks Rank #3 right now and its Most Accurate Estimate sits at $6.49 a share, just 27 days from its upcoming earnings release on August 7, 2024.
By taking the percentage difference between the $6.49 Most Accurate Estimate and the $6.18 Zacks Consensus Estimate, United Therapeutics has an Earnings ESP of 4.91%.
UTHR is one of just a large database of Medical stocks with positive ESPs. Another solid-looking stock is Recursion Pharmaceuticals (RXRX).
Slated to report earnings on August 13, 2024, Recursion Pharmaceuticals holds a #2 (Buy) ranking on the Zacks Rank, and it's Most Accurate Estimate is -$0.33 a share 33 days from its next quarterly update.
The Zacks Consensus Estimate for Recursion Pharmaceuticals is -$0.35, and when you take the percentage difference between that number and its Most Accurate Estimate, you get the Earnings ESP figure of 8.02%.
Because both stocks hold a positive Earnings ESP, UTHR and RXRX could potentially post earnings beats in their next reports.
Find Stocks to Buy or Sell Before They're Reported
Use the Zacks Earnings ESP Filter to turn up stocks with the highest probability of positively, or negatively, surprising to buy or sell before they're reported for profitable earnings season trading. Check it out here >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
United Therapeutics Corporation (UTHR) : Free Stock Analysis Report
Recursion Pharmaceuticals, Inc. (RXRX) : Free Stock Analysis Report
